Pre-hospital Prognostic Factors of 30-Day Survival in Sepsis Patients; a Retrospective Cohort Study.
Archives of Academic Emergency Medicine · 01.01.2023 · 11 (1) · e48-e48
DOI: 10.22037/aaem.v11i1.2029 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Archives of Academic Emergency Medicine, erschienen am 01.01.2023. Verfasst von Thongpitak Huabbangyang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Disaster and Emergency Medical Operation, Faculty of Science and Health Technology, Navamindradhiraj University, Bangkok, Thailand. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Themen: Sepsis
Abstract (Originalsprache)
Introduction
According to excising findings, if the emergency management system (EMS) operation will be developed, the survival outcome of sepsis patients might improve. This study aimed to evaluate the pre-hospital associated factors of survival in sepsis patients.
Methods
This retrospective cohort study was conducted on patients diagnosed with sepsis, coded with the Thailand emergency medical triage protocol and criteria-based dispatch symptom group 17. Information on the 30-day survival rate of patients was obtained from the electronic medical records. Pre-hospital factors associated with 30-day survival were analyzed using univariate and multivariate logistic regression analyses and were reported using odds ratio (OR) with 95% confidence interval (CI).
Results
300 patients diagnosed with sepsis were enrolled. Among them, 232 (77.3%) survived within 30 days. Non-survived cases had significantly older age (p = 0.019), lower oxygen saturations (92.5% vs. 95.0%; p = 0.003), higher heart rate (p = 0.001), higher respiratory rate (p < 0.001), lower level of consciousness (p < 0.001), higher disease severity based on qSOFA score (p = 0.001), and higher need for invasive airway management (p = 0.001) and supplementary oxygen (p = 0.001). The survival rate improved by 3.5% with every 1% increase in pre-hospital oxygen saturation (adjusted OR = 1.035, 95% CI: 1.005-1.066, p = 0.020) and the survival probabilities of patients who responded to voice (adjusted OR = 0.170, 95% CI: 0.050-0.579, p = 0.005), those who responded to pain (adjusted OR = 0.130, 95% CI: 0.036-0.475, p = 0.002), and those who were unresponsive (adjusted OR = 0.086, 95% CI: 0.026-0.278, p-value < 0.001) were lower than patients who were alert.
Conclusion
The 30-day survival rate of patients with sepsis managed by the EMS team was 77.3%. Pre-hospital oxygen saturation and level of consciousness were associated with the survival of patients with sepsis who were managed in the pre-hospital setting.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Disaster and Emergency Medical Operation, Faculty of Science and Health Technology, Navamindradhiraj University, Bangkok, Thailand.
- Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand.
Zitieren
APA
Huabbangyang, T., Klaiangthong, R., Jaibergban, F., Wanphen, C., Faikhao, T., Banjongkit, P., & Kuchapan, R. (2023). Pre-hospital Prognostic Factors of 30-Day Survival in Sepsis Patients; a Retrospective Cohort Study. Archives of Academic Emergency Medicine, 11(1), e48-e48. https://doi.org/10.22037/aaem.v11i1.2029
Vancouver
Huabbangyang T, Klaiangthong R, Jaibergban F, Wanphen C, Faikhao T, Banjongkit P, et al. Pre-hospital Prognostic Factors of 30-Day Survival in Sepsis Patients; a Retrospective Cohort Study. Archives of Academic Emergency Medicine. 2023;11(1):e48-e48. doi:10.22037/aaem.v11i1.2029
BibTeX
@article{Huabbangyang2023,
author = {Huabbangyang, Thongpitak and Klaiangthong, Rossakorn and Jaibergban, Fahsai and Wanphen, Chanathip and Faikhao, Thanakorn and Banjongkit, Passakorn and Kuchapan, Ratchaporn},
title = {Pre-hospital Prognostic Factors of 30-Day Survival in Sepsis Patients; a Retrospective Cohort Study},
journal = {Archives of Academic Emergency Medicine},
year = {2023},
volume = {11},
number = {1},
pages = {e48--e48},
doi = {10.22037/aaem.v11i1.2029}
}
EUVIMED